Soliman and colleagues [73] reported that Luminal A patients with Ki-67 less than 15% displayed better overall survival than luminal B with Ki-67 higher than 15%; and Ki-67 may be considered a valuable biomarker in breast cancer Egyptian patients. The gene discussed is MKI67; the disease is breast carcinoma.